what are glp-1 agonists receptor for individualized treatment of type 2 diabetes mellitus GLP-1 receptor agonists show promise
Description
Severe gastrointestinal disease, particularly gastroparesis, may alter both efficacy and tolerability and requires careful consideration
10.1016/j.pcad.2019.07.005 16 GersteinH
& Kadiyala, S
As an addiction medicine doctor, I cannot underscore this point enough: methadone, buprenorphine, naltrexone and nicotine replacement therapy are safe and effective but unacceptably under-prescribed
